{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:14:28Z","timestamp":1758845668315,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00134-023-07232-3","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T10:01:57Z","timestamp":1696413717000},"page":"1535-1537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Haloperidol and delirium: what is next?"],"prefix":"10.1007","volume":"49","author":[{"given":"Nina C.","family":"Andersen-Ranberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-0123","authenticated-orcid":false,"given":"Anders","family":"Perner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"issue":"15","key":"7232_CR1","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJMcp1605501","volume":"377","author":"ER Marcantonio","year":"2017","unstructured":"Marcantonio ER (2017) Delirium in hospitalized older adults. N Engl J Med 377(15):1456\u20131466","journal-title":"N Engl J Med"},{"issue":"9","key":"7232_CR2","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46(9):e825\u2013e873","journal-title":"Crit Care Med"},{"issue":"11","key":"7232_CR3","doi-asserted-by":"publisher","first-page":"e1111","DOI":"10.1097\/CCM.0000000000002640","volume":"45","author":"A Morandi","year":"2017","unstructured":"Morandi A et al (2017) Worldwide survey of the \u201cassessing pain, both spontaneous awakening and breathing trials, choice of drugs, delirium monitoring\/management, early exercise\/mobility, and family empowerment\u201d (ABCDEF) Bundle. Crit Care Med 45(11):e1111\u2013e1122","journal-title":"Crit Care Med"},{"issue":"7","key":"7232_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00134-018-5204-y","volume":"44","author":"MO Collet","year":"2018","unstructured":"Collet MO et al (2018) Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med 44(7):1081\u20131089","journal-title":"Intensive Care Med"},{"issue":"3","key":"7232_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0163-8343(79)90025-2","volume":"1","author":"DL Dudley","year":"1979","unstructured":"Dudley DL, Rowlett DB, Loebel PJ (1979) Emergency use of intravenous haloperidol. Gen Hosp Psychiatry 1(3):240\u2013246","journal-title":"Gen Hosp Psychiatry"},{"issue":"26","key":"7232_CR6","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","volume":"379","author":"TD Girard","year":"2018","unstructured":"Girard TD et al (2018) Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 379(26):2506\u20132516","journal-title":"N Engl J Med"},{"key":"7232_CR7","first-page":"2506","volume":"379","author":"NC Andersen-Ranberg","year":"2022","unstructured":"Andersen-Ranberg NC et al (2022) Haloperidol for the treatment of delirium in ICU patients. N Engl J Med 379:2506","journal-title":"N Engl J Med"},{"issue":"21","key":"7232_CR8","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","volume":"286","author":"E Ely","year":"2001","unstructured":"Ely E et al (2001) Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (cam-icu). JAMA 286(21):2703\u20132710","journal-title":"JAMA"},{"issue":"5","key":"7232_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s001340100909","volume":"27","author":"N Bergeron","year":"2001","unstructured":"Bergeron N et al (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27(5):859\u2013864","journal-title":"Intensive Care Med"},{"issue":"4","key":"7232_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00134-023-07024-9","volume":"49","author":"NC Andersen-Ranberg","year":"2023","unstructured":"Andersen-Ranberg NC et al (2023) Haloperidol. vs placebo for the treatment of delirium in ICU patients: a pre-planned, secondary Bayesian analysis of the AID\u2013ICU trial. Intensive Care Med 49(4):441","journal-title":"Intensive Care Med"},{"issue":"1","key":"7232_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-023-04621-4","volume":"27","author":"NC Andersen-Ranberg","year":"2023","unstructured":"Andersen-Ranberg NC et al (2023) Haloperidol for the treatment of delirium in critically ill patients: an updated systematic review with meta-analysis and trial sequential analysis. Crit Care 27(1):329","journal-title":"Crit Care"},{"issue":"1","key":"7232_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13054-016-1557-1","volume":"20","author":"JE Tomichek","year":"2016","unstructured":"Tomichek JE et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20(1):378","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-07232-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T18:02:54Z","timestamp":1702058574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-07232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7232"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-07232-3","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"type":"print","value":"0342-4642"},{"type":"electronic","value":"1432-1238"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NCAN: coordinating investigator of the AID-ICU trial, part of the trial steering committee. TDG: investigator and steering committee member for the MIND-USA Study. AP: initiator and grant holder of the AID-ICU trial, part of the trial steering committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}